Future Science Group launches RegMedNet at the World Stem Cell Summit

Share Article

Future Science Group (FSG) today unveiled RegMedNet (http://www.regmednet.com) - an interactive online resource for the regenerative medicine community.

RegMedNet

Join our community today!

Think of it as something that combines LinkedIn with Skype with blogging, but dedicated to the RegMed community

Users of RegMedNet will be able to view featured articles, interviews, webinars, industry news from FSG and select partners and much more. The site features selected content from the peer-reviewed journal Regenerative Medicine and highlights key content from other related journals. Site content and functionality is entirely free to all site registrants.

“RegMedNet will provide a virtual meeting place for experts in this exciting field” said Alexandra Thompson, Community Manager at FSG. “This field is constantly evolving, and this platform, on which members can drive the content themselves, will open a wider debate and help move the field further forward. With content and expertise shared from all areas of the field, RegMedNet is all about collaborative working and the dissemination of knowledge”.

“Think of it as something that combines LinkedIn with Skype with blogging but dedicated to the RegMed community” said Phil Garner, Managing Director at FSG. “Users can access up-to-date information and opinion, as well as communicate and collaborate with each other by using messaging and video capabilities of the site”.

RegMedNet (http://www.regmednet.com) is now live and registration is free. To launch the site, Network representatives are currently introducing RegMedNet to participants at the 2014 World Stem Cell Summit (WSCS) in San Antonio, Texas, USA (stand #43) from Dec 3-5.

WSCS is the largest interdisciplinary, networking meeting of stem cell science and regenerative medicine stakeholders, uniting the diverse community and charting the future of this burgeoning field. The WSCS attracts more than 1,400 attendees from industry, academia and government from 40 countries worldwide.

For further information please contact:
Elena Woodstock, Marketing and Public Relations, Future Science Group
T: +44 (0) 20 8371 6090 F: +44 (0) 20 8343 2313 E: e.woodstock(AT)future-science-group.com

  • - - - - - - - - - - - - - - -- - - - - - - -- - - - - - - -- - - - - - - -- - - - - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

NOTES FOR EDITORS ABOUT REGENERATIVE MEDICINE
ISSN: 1746-0751/1746-076X
Volume: Number 9 (2014)
Frequency: 8 issues per year
Senior Editor: Chris Mason, University College London, UK

Description:
Regenerative Medicine provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats– vital to an increasingly time-constrained community.

Coverage includes:

  •     Bench-to-bedside translation and scale-up of stem cell and regenerative medicine therapies
  •     Potential applications for stem cell-based strategies in pathological conditions
  •     Stem cell pluripotency and emerging technologies
  •     Tissue engineering and artificial organ development
  •     Regulatory and reimbursement issues
  •     Ethical and legal perspectives

Indexing: Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Chemical Abstracts, EMBASE/Excerpta Medica, EMCare, Journal Citation Reports/Science Edition®, MEDLINE/Index Medicus, Science Citation Index Expanded™ (SciSearch®) and Scopus

  • - - - - - - - - - - - - - - -- - - - - - - -- - - - - - - -- - - - - - - -- - - - - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ABOUT FUTURE SCIENCE GROUP
Founded in 2001, Future Science Group is progressive publisher focused on breakthrough medical, biotechnological and scientific research.

Future Science Group’s portfolio consists of two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, Future Science Group develops specialist eCommunities. The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value- for-money and uncompromising high standards. Learn more about Future Science Group at http://www.future-science-group.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Elena Woodstock
Visit website